registrieren | anmelden | FAQ      [?] 

Cardiovascular Diabetology - Latest articles

Articles from the last few issues of Cardiovascular Diabetology - Latest articles
  • The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
    Cardiovascular Diabetology, Vol. 7 (07 October 2008), 29.
    by Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands, Andries Smit
  • Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects
    Cardiovascular Diabetology, Vol. 7, No. 1. (2008)
    by Odd E Johansen, Ellen Brustad, Steve Enger, Arnljot Tveit
    posted by 1 person boylucas
  • Metabolic syndrome according to different definitions in a rapidly developing country of the African region
    Cardiovascular Diabetology, Vol. 7 (18 September 2008), 27.
    by Clara Kelliny, Julita William, Walter Riesen, Fred Paccaud, Pascal Bovet
  • Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats.
    Cardiovascular Diabetology, Vol. 7 (02 September 2008), 26.
    by Bernard Cosyns, Steven Droogmans, Sophie Hernot, Celine Degaillier, Christian Garbar, Caroline Weytjens, Bram Roosens, Danny Schoors, Tony Lahoutte, Philippe R Franken, Guy Van Camp
  • Anaemia and kidney dysfunction in Caribbean Type 2 diabetic patients
    Cardiovascular Diabetology, Vol. 7 (27 August 2008), 25.
    by Chidum E Ezenwaka, Altheia Jones-Lecointe, Emeka Nwagbara, Dawn Seales, Fidelis Okali
  • Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
    Cardiovascular Diabetology, Vol. 7 (11 August 2008), 24.
    by Anette Woehl, Marc Evans, Anthony P Tetlow, Philip Mcewan
  • Interaction between Calpain-5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.
    Cardiovascular Diabetology, Vol. 7 (25 July 2008), 23.
    by Maria E Saez, Antonio Grilo, Francisco J Moron, Luis Manzano, Maria T Martinez-Larrad, Antonio Gonzalez-Perez, Francisco J Serrano-Hernando, Agustin Ruiz, Reposo Ramirez-Lorca, Manuel Serrano-Rios
  • First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation
    Cardiovascular Diabetology, Vol. 7 (24 July 2008), 22.
    by Walter Zidek, Joachim Schrader, Stephan Luders, Stephan Matthaei, Christoph Hasslacher, Joachim Hoyer, Peter Bramlage, Claus-Dieter Sturm, Dieter W Paar
  • The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD. A Pilot 2x2 Factorial "Understanding Risk" Trial.
    Cardiovascular Diabetology, Vol. 7 (17 July 2008), 21.
    by Hermione C Price, Lynne Tucker, Simon J Griffin, Rury R Holman
    posted by 1 person xdebussche
  • Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment
    Cardiovascular Diabetology, Vol. 7 (22 June 2008), 20.
    by Raymond Farah, Revital Shurts-Swirzki, Olga Lapin
    posted by 1 person booker
  • Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats
    Cardiovascular Diabetology, Vol. 7 (21 June 2008), 19.
    by Marlene F Shehata
  • Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
    Cardiovascular Diabetology, Vol. 7 (19 June 2008), 18.
    by Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, Ilan Goldenberg, Yehuda Adler, Micha S Feinberg, Michael Motro, David Tanne, Joseph Shemesh, Ehud Schwammenthal, Solomon Behar
  • On the use of a continuous metabolic syndrome score in pediatric research
    Cardiovascular Diabetology, Vol. 7 (05 June 2008), 17.
    by Joey C Eisenmann
  • Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure.
    Cardiovascular Diabetology, Vol. 7 (29 May 2008), 16.
    by Yumi Miyashita, Rimei Nishimura, Masami Nemoto, Toru Matsudaira, Tamotsu Yokota, Hideaki Kurata, Kuninobu Yokota, Katsuyoshi Tojo, Kazunori Utsunomiya, Naoko Tajima
  • Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes
    Cardiovascular Diabetology, Vol. 7 (23 May 2008), 15.
    by Richard J Macisaac, Merlin C Thomas, Sianna Panagiotopoulos, Trudy J Smith, Huming Hao, Geoffrey D Matthews, George Jerums, Louise M Burrell, Piyush M Srivastava
  • Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth
    Cardiovascular Diabetology, Vol. 7 (18 May 2008), 14.
    by Daniela Germani, Antonella Puglianiello, Stefano Cianfarani
  • Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice
    Cardiovascular Diabetology, Vol. 7 (01 May 2008), 13.
    by Riikka Kivela, Mika Silvennoinen, Maarit Lehti, Sanni Jalava, Veikko Vihko, Heikki Kainulainen
    posted by 1 person cchand
  • Treatment with pioglitazone induced significant, reversible mitral regurgitation
    Cardiovascular Diabetology, Vol. 7 (30 April 2008), 12.
    by Mozhgan Dorkhan, Magnus Dencker, Anders Frid
  • Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform
    Cardiovascular Diabetology, Vol. 7 (25 April 2008), 11.
    by Osamu Ogawa, Kiyoko Hiraoka, Takahiro Watanabe, Junichiro Kinoshita, Masahiko Kawasumi, Hidenori Yoshii, Ryuzo Kawamori
  • Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study)
    Cardiovascular Diabetology, Vol. 7 (24 April 2008), 10.
    by Michel Komajda, Paula Curtis, Markolf Hanefeld, Henning Beck-Nielsen, Stuart J Pocock, Andrew Zambanini, Nigel P Jones, Ramon Gomis, Philip D Home, For
  • Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus
    Cardiovascular Diabetology, Vol. 7 (22 April 2008), 9.
    by Xilin Yang, Ronald C Ma, Wing-Yee So, Alice P Kong, Gary T Ko, Chun-Shun Ho, Christopher W Lam, Clive S Cockram, Peter C Tong, Juliana C Chan
  • In vivo endothelial gene regulation in diabetes
    Cardiovascular Diabetology, Vol. 7 (19 April 2008), 8.
    by Gregory J Maresh, Ralph V Shohet
  • Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats
    Cardiovascular Diabetology, Vol. 7 (08 April 2008), 7.
    by Marlene F Shehata
  • Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?
    Cardiovascular Diabetology, Vol. 7, No. 1. (2008)
    by Osman Gani
  • Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample
    Cardiovascular Diabetology, Vol. 7 (13 March 2008), 5.
    by Salam A Al-Attar, Rebecca L Pollex, Matthew R Ban, Kue T Young, Peter Bjerregaard, Sonia S Anand, Salim Yusuf, Bernard Zinman, Stewart B Harris, Anthony JG Hanley, Philip W Connelly, Murray W Huff, Robert A Hegele
  • Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity?
    Cardiovascular Diabetology, Vol. 7 (28 February 2008), 4.
    by Chaoyang Li, Earl S Ford, Yuan-Xiang Meng, Ali H Mokdad, Gerald M Reaven
  • Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model
    Cardiovascular Diabetology, Vol. 7 (26 February 2008), 3.
  • Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus
    Cardiovascular Diabetology, Vol. 7 (04 February 2008), 2.
    by Olga Bilim, Yasuchika Takeishi, Tatsuro Kitahara, Takanori Arimoto, Takeshi Niizeki, Toshiki Sasaki, Kaoru Goto, Isao Kubota
  • Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus
    Cardiovascular Diabetology, Vol. 7 (02 January 2008), 1.
    by Nicholas Tentolouris, Athanasia Papazafiropoulou, Ioannis Moyssakis, Stavros Liatis, Despoina Perrea, Maria Kostakis, Nicholas Katsilambros
    posted by 1 person omalbam
  • The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery
    Cardiovascular Diabetology, Vol. 6 (17 December 2007), 39.
    by Mathijs Vogelzang, Miriam Hoekstra, Jose T Drost, Marcel Janse, Iwan CC van der Horst, Piet W Boonstra, Felix Zijlstra, Bert G Loef, Maarten WN Nijsten
  • Maximal exercise test is a useful method for physical capacity and oxygen consumption determination in streptozotocin-diabetic rats
    Cardiovascular Diabetology, Vol. 6 (13 December 2007), 38.
    by Bruno Rodrigues, Diego M Figueroa, Cristiano T Mostarda, Marcelo V Heeren, Maria-Claudia Irigoyen, Katia De Angelis
  • Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry
    Cardiovascular Diabetology, Vol. 6 (02 December 2007), 37.
    by Xilin Yang, Ronald C Ma, Wing-Yee So, Gary T Ko, Alice P Kong, Christopher W Lam, Chun-Shun Ho, Clive S Cockram, Vivien C Wong, Peter C Tong, Juliana C Chan
  • Effect of the Angiotensin Receptor Blocker Irbesartan on Metabolic Parameters in Clinical Practice: the DO-IT Prospective Observational Study
    Cardiovascular Diabetology, Vol. 6 (27 November 2007), 36.
    by Klaus G Parhofer, Felix Muenzel, Michael Krekler
  • The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes
    Cardiovascular Diabetology, Vol. 6 (30 October 2007), 35.
    by Raffaele Marfella, Michele D'Amico, Clara Di Filippo, Mario Siniscalchi, Ferdinando C Sasso, Franca Ferraraccio, Francesco Rossi, Giuseppe Paolisso
    posted by 1 person jyuh
  • Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development
    Cardiovascular Diabetology, Vol. 6 (30 October 2007), 34.
    by Srinivasan D Kumar, Thameem S Dheen, Samuel
  • Anti-proliferative activity of oral anti hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions
    Cardiovascular Diabetology, Vol. 6 (28 October 2007), 33.
    by Peter J Little, Narin Osman, Stephanie T de Dios, Nelly Cemerlang, Mandy Ballinger, Julie Nigro
  • Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity
    Cardiovascular Diabetology, Vol. 6 (24 October 2007), 32.
    by David Faeh, Julita William, Patrick Yerly, Fred Paccaud, Pascal Bovet
  • Waist circumference does not predict circulating adiponectin levels in sub-Saharan African women
    Cardiovascular Diabetology, Vol. 6 (16 October 2007), 31.
    by Eugene Sobngwi, Valery Effoe, Philippe Boudou, Dieudonne Njamen, Jean-Francois Gautier, Jean-Claude Mbanya
  • Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study
    Cardiovascular Diabetology, Vol. 6 (15 October 2007), 30.
    by Bernard Cosyns, Steven Droogmans, Caroline Weytjens, Tony Lahoutte, Guy Van Camp, Danny Schoors, Philippe R Franken
  • The progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndrome
    Cardiovascular Diabetology, Vol. 6 (05 October 2007), 29.
    by Muammer Karadeniz, Mehmet Erdogan, Afig Berdeli, Sadik Tamsel, Fusun Saygili, Candeger Yilmaz
  • Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
    Cardiovascular Diabetology, Vol. 6 (02 October 2007), 28.
    by Arya M Sharma, Jaime Davidson, Stephen Koval, Yves Lacourciere
  • Abdominal obesity exhibits distinct effect on inflammatory network in apparently healthy Japanese men
    Cardiovascular Diabetology, Vol. 6 (01 October 2007), 27.
    by Makoto Nishida, Toshiki Moriyama, Yoshiro Sugita, Keiko Yamauchi-Takihara
  • Angiotensin II receptor blockers decreased blood glucose levels: a longitudinal survey using data from electronic medical records
    Cardiovascular Diabetology, Vol. 6 (29 September 2007), 26.
    by Noboru Kitamura, Yasuo Takahashi, Shuukoh Yamadate, Satoshi Asai
  • Trends in hyperlipidemia and hypertension management in type 2 diabetes patients from 1998-2004: a longitudinal observational study
    Cardiovascular Diabetology, Vol. 6 (20 September 2007), 25.
    by Jacoba P Greving, Petra Denig, Dick de Zeeuw, Henk JG Bilo, Flora M Haaijer-Ruskamp
    posted by 1 person mapujols
  • The prevalence of macrovascular complications among diabetic patients in the United Arab Emirates
    Cardiovascular Diabetology, Vol. 6 (19 September 2007), 24.
    by Fatma Al-Maskari, Mohammed El-Sadig, John N Norman
  • Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography
    Cardiovascular Diabetology, Vol. 6 (07 September 2007), 23.
    by Masami Nemoto, Rimei Nishimura, Takashi Sasaki, Yoshito Hiki, Yumi Miyashita, Makiko Nishioka, Kei Fujimoto, Toru Sakuma, Toya Ohashi, Kunihiko Fukuda, Yoshikatsu Eto, Naoko Tajima
  • Impact of 4 different definitions used for the assessment of the prevalence of the Metabolic Syndrome in primary healthcare: The German Metabolic and Cardiovascular Risk Project
    Cardiovascular Diabetology, Vol. 6 (06 September 2007), 22.
    by Susanne Moebus, Jens U Hanisch, Pamela Aidelsburger, Peter Bramlage, Juergen Wasem, Karl-Heinz Joeckel
  • Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes.
    Cardiovascular Diabetology, Vol. 6 (22 August 2007), 21.
    by Joanna R Worley, David A Hughes, Nicoletta Dozio, Jelena Gavrilovic, Mike J Sampson
  • Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes
    Cardiovascular Diabetology, Vol. 6 (15 August 2007), 20.
    by Markolf Hanefeld
  • Serum transforming growth factor beta-1 (TGF- b1) levels in diabetic patients are not associated with pre-existent coronary artery disease
    Cardiovascular Diabetology, Vol. 6 (25 July 2007), 19.
    by Beatriz D Schaan, Alexandre S Quadros, Rogerio Sarmento-Leite, Giuseppe De Lucca, Alexandra Bender, Marcello Bertoluci
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/journal/cardiab

    Result page: 1 2 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.